Thursday 23 October 2008, 12:00AM
PEARLS 116, October 2008, written by Brian R
McAvoy
Clinical question
How effective is antiviral therapy in Ramsay Hunt
syndrome (herpes zoster oticus with facial palsy)?
Bottom line
The review found no evidence that antiviral therapy had a
beneficial effect on outcomes in Ramsay Hunt syndrome. Only one
randomised controlled trial was identified, comparing acyclovir and
corticosteroids with corticosteroids alone.There was no
statistically signifi•cant difference in outcomes between the two
groups.
Caveat
The single study was of low quality and included only 15
participants.As usual, the absence of positive evidence of benefit
(or in this case, the "negative" result of one small, statistically
under-powered study) does not necessarily indicate that antivirals
are ineffective. On the basis of fundamental pathophysiological
principles, it would seem reasonable to use them. However, these
drugs are associated with a number of adverse effects (such as
nausea, headache, renal impairment, diarrhoea, dizziness, fatigue,
skin rash, anorexia, leg pain, sore throat and hair loss), and this
must be taken into consideration when undertaking the requisite
risk-benefit analysis before instigating treatment.
Context
Herpes zoster oticus is a viral infection of the inner, middle and
external ear, and when associated with acute facial paralysis is
known as Ramsay Hunt syndrome. Antiviral agents are the standard
first-line treatment for herpes zoster infections at other body
sites, and are thought to reduce or minimise nerve damage, thereby
improving outcomes.
Cochrane Systematic Review
Uscategui T et al.Antiviral therapy for Ramsay Hunt
syndrome (herpes zoster oticus with facial palsy) in adults.
Cochrane Reviews 2008, Issue 4. Article No. CD006851. DOI:
10.1002/14651858. CD006851.pub2. This review contains one trial
involving 15 participants.